Study details
Enrolling now
Dime La VerDAD: Verify, Debunk, and Disseminate
University of Chicago
NCT IDNCT06417762ClinicalTrials.gov data as of Apr 2026
Target enrollment
1,400
Study length
about 3.8 years
Ages
18–99
Locations
4 sites in IA, IL, MI
What this study is about
This trial is testing a program that helps community health workers share personal stories on social media to combat vaccine misinformation. The goal is to see if this approach can change people's opinions about COVID-19 and flu vaccines in Hispanic communities.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Participate in Science Communication Curriculum Cohort 1
- 2.Participate in Science communication curriculum Cohort 2
- 3.Participate in Science communication curriculum Cohort 3
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Body systems
Infectious, Respiratory